REYON Pharmaceutical Co., Ltd. (KRX:102460)

REYON Pharmaceutical Revenue

REYON Pharmaceutical had revenue of 37.69B KRW in the quarter ending June 30, 2025, with 5.64% growth. This brings the company's revenue in the last twelve months to 150.05B, up 0.71% year-over-year. In the year 2024, REYON Pharmaceutical had annual revenue of 148.30B, down -1.83%.

• Revenue (ttm): 150.05B
• Revenue Growth: +0.71%
• P/S Ratio: 1.37
• Revenue / Employee: 341.03M
• Employees: 440
• Market Cap: 206.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	148.30B	-2.77B	-1.83%
Dec 31, 2023	151.07B	-2.97B	-1.93%
Dec 31, 2022	154.04B	11.24B	7.87%
Dec 31, 2021	142.80B	12.77B	9.82%
Dec 31, 2020	130.03B	-1.52B	-1.16%